BIOXCEL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.96 USD | +3.86% |
|
+10.45% | +0.34% |
Chart calendar BioXcel Therapeutics, Inc.
370ecec8.5-0U3LDRkNjHS1bsMePIOrnSGBQei5JQbp6Q8Ef_2hU.tt59kYmkveikLDOLfIWsb_GeQUR9sstgHe-muSubgFGLtDmehfyok4QgMQ~ac6d9d57562c0ddf95df9231d6d6d3b8
Upcoming events on BioXcel Therapeutics, Inc.
Past events on BioXcel Therapeutics, Inc.
| 2024-03-12 08:00 am | Q4 2023 Earnings Call |
| 2024-03-12 07:00 am | Q4 2023 Earnings Release |
| 2023-12-12 01:00 pm | R&D Day |
| 2023-11-14 08:00 am | Q3 2023 Earnings Call |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-10-10 08:00 am | BXCL701 Phase 2 Trial Results Call |
| 2023-08-14 08:00 am | Q2 2023 Earnings Call |
| 2023-08-14 07:00 am | Q2 2023 Earnings Release |
| 2023-06-29 08:00 am | BXCL501 Phase 3 Trial Results Call |
| 2023-06-26 09:00 am | Annual General Meeting |
| 2023-06-14 05:40 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 02:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-25 08:00 am | BXCL501 Phase 3 Trial Results Call |
| 2023-05-09 01:15 pm | Bank of America Healthcare Conference - Fireside Chat |
| 2023-05-08 08:00 am | Q1 2023 Earnings Call |
| 2023-05-08 07:00 am | Q1 2023 Earnings Release |
| 2023-03-09 08:30 am | Q4 2022 Earnings Call |
| 2023-03-09 07:00 am | Q4 2022 Earnings Release |
| 2023-02-21 01:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-02-16 07:45 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract Number: 176 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,38 1,18 -68.31% | 1,38 1,71 -19.48% | 3,50 |
|
EBITDA Million USD | Released Forecast Spread | -33,4 -37,6 11.05% | -82,1 -83,1 1.19% | -107 -107 0.11% | -159 -143 -11.33% | -172 -173 1.01% | -90,9 |
|
EBIT Million USD | Released Forecast Spread | -33,6 -36,2 7.2% | -82,3 -82,2 -0.17% | -107 -109 1.48% | -160 -146 -9.01% | -172 -176 2.37% | -95,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,0 -35,6 7.35% | -82,2 -81,9 -0.3% | -107 -110 2.88% | -166 -152 -9.41% | -179 -184 2.64% | -105 |
|
Net income Million USD | Released Forecast Spread | -33,0 -36,4 9.55% | -82,2 -83,8 1.92% | -107 -114 6.59% | -166 -151 -9.58% | -179 -183 2.2% | -105 |
|
EPS USD | Released Forecast Spread | -2,02 -2,22 9.01% | -3,79 -3,83 0.97% | -4,05 -4,27 5.04% | -5,92 -5,29 -11.86% | -6,15 -6,18 0.47% | -3,12 |
| Announcement Date | 09/03/20 | 11/03/21 | 10/03/22 | 09/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,13 - | 0,00 0,00 - | 0,14 1,00 -86.37% | 0,24 1,08 -77.93% | 0,21 0,32 -36.37% | 0,46 0,47 -2.12% | 0,34 0,63 -45.53% | 0,38 0,74 -49.28% | 0,67 | 0,71 | 0,83 | 0,92 |
|
EBITDA Million USD | Released Forecast Spread | -26,1 -30,2 13.68% | -31,4 -30,0 -4.85% | -36,2 -33,3 -8.72% | -38,9 -36,1 -7.68% | -52,8 -36,5 -44.64% | -51,1 -44,4 -15.2% | -52,3 -48,3 -8.38% | -48,2 -39,8 -21.27% | -19,6 -28,0 30.16% | -19,8 | -21,7 | -23,6 | -26,0 |
|
EBIT Million USD | Released Forecast Spread | -26,1 -30,9 15.48% | -31,5 -31,3 -0.68% | -36,3 -34,2 -6.09% | -39,0 -37,2 -4.8% | -52,9 -40,9 -29.19% | -51,2 -43,9 -16.67% | -52,4 -49,4 -6.12% | -48,3 -37,7 -28.22% | -19,9 -26,7 25.62% | -20,6 | -22,9 | -24,5 | -26,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,1 -29,3 10.9% | -31,5 -31,6 0.55% | -37,7 -34,5 -9.11% | -41,8 -38,2 -9.34% | -54,8 -41,9 -30.72% | -52,8 -45,4 -16.41% | -53,5 -51,2 -4.6% | -50,5 -36,3 -39.21% | -22,3 -27,8 19.98% | -23,8 | -25,6 | -27,6 | -28,2 |
|
Net income Million USD | Released Forecast Spread | -26,1 -32,8 20.44% | -31,5 -32,0 1.51% | -37,7 -35,0 -7.56% | -41,8 -38,8 -7.7% | -54,8 -41,9 -30.9% | -52,8 -46,7 -13% | -53,5 -51,0 -4.87% | -50,5 -36,5 -38.28% | -22,3 -27,8 19.98% | -23,8 | -25,6 | -27,6 | -28,2 |
|
EPS USD | Released Forecast Spread | -0,93 -1,14 18.34% | -1,12 -1,13 0.76% | -1,35 -1,23 -9.34% | -1,49 -1,34 -11.01% | -1,95 -1,44 -35.11% | -1,84 -1,57 -17.27% | -1,83 -1,72 -6.39% | -1,72 -1,24 -38.53% | -0,76 -0,91 16.16% | -0,81 | -0,86 | -0,74 | -0,78 |
| Announcement Date | 10/03/22 | 09/05/22 | 09/08/22 | 10/11/22 | 09/03/23 | 09/05/23 | 14/08/23 | 14/11/23 | 12/03/24 | - | - | - | - |
More events
Past sector events for BioXcel Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BTAI Stock
- Calendar BioXcel Therapeutics, Inc.
